Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2008.04.22, JP 2008111745
GRONLUND-PAKKANEN ET AL: "The Fluorescence Biodistribution And Kinetics Of Aminolevulinic Acid Induced Protoporphyrin IX In The Bladder Of A Rat Model With Orthotopic Urothelial Carcinoma", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 167, no. 4, 1 April 2002 (2002-04-01) , pages 1848-1853, XP005543745, ISSN: 0022-5347, DOI: 10.1016/S0022-5347(05)65247-0 (B1)
ZHENGWEN XIAO ET AL: "Biodistribution of Photofrin II and 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Normal Rat Bladder and Bladder Tumor Models: Implications for Photodynamic Therapy", PHOTOCHEMISTRY AND PHOTOBIOLOGY, vol. 67, no. 5, 1 May 1998 (1998-05-01), pages 573-583, XP055139678, ISSN: 0031-8655, DOI: 10.1111/j.1751-1097.1998.tb09096.x (B1)
HARUKI AKASU ET AL.: '5-ALA ni yoru Jucchu Fukukojosen no Keiko Hakkoteki Dotei 10-rei no Kento' FOLIA ENDOCRINOLOGICA JAPONICA vol. 81, no. 1, 2005, page 174, XP008143039 (B1)
HORNUNG, R. ET AL.: 'In vivo detection of metastatic ovarian cancer by means of 5-aminolevulinic acid-induced fluorescence in a rat model' J AM ASSOC GYNECOL LAPAROSC vol. 5, no. 2, 1998, pages 141 - 148, XP008143073 (B1)
Inc Association ET AL: "0022-5347/95/1533-0802$03.00/0 TH!3 JOURNAL OF UROLOGY Copyright 0 1995 by AMERICAN U R O ~ I C A L BIODISTRIBUTION AND PHOTOTOXICITY OF 5-AMINOLEVULINIC ACID-INDUCED PpIX IN AN ORTHOTOPIC RAT BLADDER TUMOR MODEL From the Wellman Laboratories of Photomedicine and the Departments of Urology and Derma", , 1 March 1995 (1995-03-01), pages 802-806, XP055139758, Retrieved from the Internet: URL:http://ac.els-cdn.com/S002253470167726 7/1-s2.0-S0022534701677267-main.pdf?_tid=6 4102cce-39c6-11e4-8875-00000aacb35f&acdnat =1410448677_a5b14cd2bd51e77f2c33082ea56e9f 85 [retrieved on 2014-09-11] (B1)
JOHANSSON, J. ET AL.: 'Laser-induced fluorescence studies of normal and malignant tumour tissue of rat following intravenous injection of delta-amino levulinic acid' LASERS SURG MED vol. 20, no. 3, 1997, pages 272 - 279, XP008143048 (B1)
JP-T- 2002 512 205 (B1)
KAMASAKI, N. ET AL.: 'Photodynamic Diagnosis of Squamous Cell Carcinoma in Mouse Tongue Using 5-aminolevulinic Acid.' THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE vol. 22, no. 4, 2001, pages 255 - 262, XP008144824 (B1)
KENJI INOUE ET AL.: 'CLINICAL EXPERIENCE WITH INTRAVESICAL INSTILLATIONS OF 5-AMINOLEVULINIC ACID (5-ALA) FOR THE PHOTODYNAMIC DIAGNOSIS USING FLUORESCENCE CYSTOSCOPY FOR BLADDER CANCER' THE JAPANESE JOURNAL OF UROLOGY vol. 97, no. 5, 2006, pages 719 - 729, XP008143050 (B1)
MANIVASAGER VANAJA ET AL: "A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer", INTERNATIONAL JOURNAL OF ONCOLOGY, DEMETRIOS A. SPANDIDOS ED. & PUB, GR, vol. 22, no. 2, 1 February 2003 (2003-02-01), pages 313-318, XP009148822, ISSN: 1019-6439 (B1)
NORIO MIYOSHI ET AL.: '5-Aminolevulinic acid (5-ALA) o Toyo shita Shuyonai Taishabutsu Protoporphyrin-IX(Pp-IX) no Keiko Bunseki' THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE vol. 23, 2002, pages 81 - 85, 87,, XP008144825 (B1)
US-A1- 2003 158 258 (B1)
US-A1- 2005 031 541 (B1)
VAN, S.T. ET AL.: 'Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA' LASERS MED SCI vol. 17, no. 4, 2002, pages 238 - 245, XP008143069 (B1)
WAIDELICH ET AL: "CLINICAL EXPERIENCE WITH 5-AMINOLEVULINIC ACID AND PHOTODYNAMIC THERAPY FOR REFRACTORY SUPERFICIAL BLADDER CANCER", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 165, no. 6, 1 June 2001 (2001-06-01), pages 1904-1907, XP005544839, ISSN: 0022-5347, DOI: 10.1016/S0022-5347(05)66239-8 (B1)
YUKO MINAMI ET AL.: 'Aminolevulinic Acid o Mochiita Haimonbu Haigan no Keiko Shindan' JAPANESE JOURNAL OF LUNG CANCER vol. 42, no. 5, 2002, page 374, XP008143042 (B1)
ZAAK D ET AL: "Photodynamic Diagnosis of Prostate Cancer Using 5-Aminolevulinic Acid-First Clinical Experiences", UROLOGY, BELLE MEAD, NJ, US, vol. 72, no. 2, 11 April 2008 (2008-04-11) , pages 345-348, XP023520570, ISSN: 0090-4295, DOI: 10.1016/J.UROLOGY.2007.12.086 [retrieved on 2008-04-11] (B1)
GRONLUND-PAKKANEN, S. ET AL.: 'The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma' J UROL vol. 167, no. 4, 2002, pages 1848 - 1853, XP005543745 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP2272538)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP2272538)
|
Innkommende, AR394070819
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 17. avg. år (EP) expand_more expand_less | 2025.04.09 | 7150,0 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 17. avg. år (EP)
7150,0 = 1 X 7150,0
En ordre på saken er opprettet av: Supplier Payments (08.04.2025 07:27:39): Betalt |
||||
Årsavgift 16. avg. år (EP) | 2024.04.09 | 6760 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 15. avg. år (EP) | 2023.04.12 | 4850 | CPA GLOBAL LIMITED | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2022.04.25 | 4500 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
Årsavgift 13. avg. år (EP) | 2021.04.22 | 4200 | 1/DENNEMEYER CO S.A R.L. | Betalt og godkjent |
32015877 expand_more expand_less | 2020.11.23 | 5500 | TANDBERG INNOVATION AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|